Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 3.782.822.952.812.26

What is the latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS is 3.78 based on Mar2024 Standalone results.
Year Working Capital/Sales
Mar20243.78
Mar20232.82
Mar20222.95
Mar20212.81
Mar20202.26

How is Working Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2024 3.78
34.04
Mar2023 2.82
-4.41
Mar2022 2.95
4.98
Mar2021 2.81
24.34
Mar2020 2.26 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹172.4 Cr -9.7% -7.6% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-9.7%

-7.6%

-26.1%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses